Evidence map›Paper›PMID 31894627›Full record

ArticlePigment cell & melanoma research2020

Protective role of mouse mast cell tryptase Mcpt6 in melanoma.

Mirjana Grujic, Lars Hellman, Ann-Marie Gustafson, Srinivas Akula, Fabio Rabelo Melo, Gunnar Pejler

Open access · hybridAbstract read
In one paragraph

Article in Pigment cell & melanoma research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Interactions Between Tryptase-Positive Mast Cells and Melanin-AInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Protease Profile of Tumor-Associated Mast Cells in Melanoma.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Mast Cell β-Tryptase Is Enzymatically Stabilized by DNA.International journal of molecular sciences · 2020
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mirjana GrujicDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Lars HellmanDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Ann-Marie GustafsonDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Srinivas AkulaDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Fabio Rabelo MeloDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Gunnar PejlerDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-6779-391X
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptase-positive mast cells populate melanomas, but it is not known whether tryptase impacts on melanoma progression. Here we addressed this and show that melanoma growth is significantly higher in tryptase-deficient (Mcpt6

Indexed as

AnimalsBiomarkers, TumorCarcinogenesisCell Line, TumorCell ProliferationChemokine CXCL9Gene Expression Regulation, NeoplasticInterferon-gammaMast CellsMelanomaMice, Inbred C57BLProtective AgentsRecombinant ProteinsSkin NeoplasmsStromal CellsSubcutaneous TissueBiomarkers, TumorChemokine CXCL9Interferon-gammaProtective AgentsRecombinant ProteinsTpsb2 protein, mouseTryptasesCXCL9mast cellsMcpt6melanomatryptase

Identifiers

PMID31894627
PMCPMC7317424
OpenAlexW2997855119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.